Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy M Palmer

Showing results (21-30 of 46) with videos related to

Pageof 5
Sort By:
The Journal of Biological Chemistry|May 9, 2009
Activation of protein kinase Calpha by EPAC1 is required for the ERK- and CCAAT/enhancer-binding protein beta-dependent induction of the SOCS-3 gene by cyclic AMP in COS1 cellsGillian Borland, Rebecca J Bird, Timothy M Palmer, et al.
Molecular Pharmacology|August 3, 2004
Specific inhibition of nuclear factor-kappaB-dependent inflammatory responses by cell type-specific mechanisms upon A2A adenosine receptor gene transferWilliam A Sands, Anthony F Martin, Elaine W Strong, et al.
Methods in Molecular Biology (Clifton, N.J.)|November 25, 2011
Exchange protein directly activated by cyclic AMP-1-regulated recruitment of CCAAT/enhancer-binding proteins to the suppressor of cytokine signaling-3 promoterWilliam A Sands, Hayley D Woolson, Stephen J Yarwood, et al.
Trends in Pharmacological Sciences|April 6, 2019
Targeting SOCS Proteins to Control JAK-STAT Signalling in DiseaseGillian A Durham, Jamie J L Williams, M Talat Nasim, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|April 4, 2021
Revascularisation of type 2 diabetics with coronary artery disease: Insights and therapeutic targeting of O-GlcNAcylationIsrael O Bolanle, Kirsten Riches-Suman, Mahmoud Loubani, et al.
Molecular Pharmacology|February 27, 2010
Priming of signal transducer and activator of transcription proteins for cytokine-triggered polyubiquitylation and degradation by the A 2A adenosine receptorMohammed M A Safhi, Claire Rutherford, Catherine Ledent, et al.
Molecular and Cellular Biology|August 18, 2006
Exchange protein activated by cyclic AMP (Epac)-mediated induction of suppressor of cytokine signaling 3 (SOCS-3) in vascular endothelial cellsWilliam A Sands, Hayley D Woolson, Gillian R Milne, et al.
Cells|January 28, 2026
Inhibition of the JAK and MEK Pathways Limits Mitochondrial ROS Production in Human Saphenous Vein Smooth Muscle CellsIsrael O Bolanle, James P Hobkirk, Mahmoud Loubani, et al.
Pharmacological Research|October 18, 2017
Linking energy sensing to suppression of JAK-STAT signalling: A potential route for repurposing AMPK activators?Claire Speirs, Jamie J L Williams, Kirsten Riches, et al.
Cellular Signalling|July 28, 2009
Selective inhibition of cytokine-activated extracellular signal-regulated kinase by cyclic AMP via Epac1-dependent induction of suppressor of cytokine signalling-3Hayley D Woolson, Victoria S Thomson, Claire Rutherford, et al.
Pageof 5

Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
The Journal of Biological Chemistry|May 9, 2009
Activation of protein kinase Calpha by EPAC1 is required for the ERK- and CCAAT/enhancer-binding protein beta-dependent induction of the SOCS-3 gene by cyclic AMP in COS1 cellsGillian Borland, Rebecca J Bird, Timothy M Palmer, et al.
Molecular Pharmacology|August 3, 2004
Specific inhibition of nuclear factor-kappaB-dependent inflammatory responses by cell type-specific mechanisms upon A2A adenosine receptor gene transferWilliam A Sands, Anthony F Martin, Elaine W Strong, et al.
Methods in Molecular Biology (Clifton, N.J.)|November 25, 2011
Exchange protein directly activated by cyclic AMP-1-regulated recruitment of CCAAT/enhancer-binding proteins to the suppressor of cytokine signaling-3 promoterWilliam A Sands, Hayley D Woolson, Stephen J Yarwood, et al.
Trends in Pharmacological Sciences|April 6, 2019
Targeting SOCS Proteins to Control JAK-STAT Signalling in DiseaseGillian A Durham, Jamie J L Williams, M Talat Nasim, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|April 4, 2021
Revascularisation of type 2 diabetics with coronary artery disease: Insights and therapeutic targeting of O-GlcNAcylationIsrael O Bolanle, Kirsten Riches-Suman, Mahmoud Loubani, et al.
Molecular Pharmacology|February 27, 2010
Priming of signal transducer and activator of transcription proteins for cytokine-triggered polyubiquitylation and degradation by the A 2A adenosine receptorMohammed M A Safhi, Claire Rutherford, Catherine Ledent, et al.
Molecular and Cellular Biology|August 18, 2006
Exchange protein activated by cyclic AMP (Epac)-mediated induction of suppressor of cytokine signaling 3 (SOCS-3) in vascular endothelial cellsWilliam A Sands, Hayley D Woolson, Gillian R Milne, et al.
Cells|January 28, 2026
Inhibition of the JAK and MEK Pathways Limits Mitochondrial ROS Production in Human Saphenous Vein Smooth Muscle CellsIsrael O Bolanle, James P Hobkirk, Mahmoud Loubani, et al.
Pharmacological Research|October 18, 2017
Linking energy sensing to suppression of JAK-STAT signalling: A potential route for repurposing AMPK activators?Claire Speirs, Jamie J L Williams, Kirsten Riches, et al.
Cellular Signalling|July 28, 2009
Selective inhibition of cytokine-activated extracellular signal-regulated kinase by cyclic AMP via Epac1-dependent induction of suppressor of cytokine signalling-3Hayley D Woolson, Victoria S Thomson, Claire Rutherford, et al.
Pageof 5